Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
15-Aug-25 | Buy | Roch Doliveux | 449.75p | 67,000 | £301,332.50 |
18-Aug-25 | Sell | Dame Kay Davies | 500.40p | 4,563 | £22,833.25 |
Notifier | Holding | Value* |
---|---|---|
Roch Doliveux | 376,808 | £2,268,384 |
Heather Preston | 29,687 | £178,716 |
Frank Mathias | 20,000 | £120,400 |
Namrata P Patel | 9,170 | £55,203 |
Dame Kay Davies | 1,000 | £6,020 |
Notifier** | Holding | Value* |
---|---|---|
Briarwood Chase Management LLC | 18,638,801 | £112,205,582 |
Briarwood Chase Management LLC | 13,851,927 | £83,388,600 |
Novo Nordisk Foundation | 12,048,802 | £72,533,788 |
Institut Merieux SA | 11,510,481 | £69,293,096 |
VULPES LIFE SCIENCES FUND | 8,447,390 | £50,853,288 |
Liontrust Asset Management | 6,078,799 | £36,594,370 |
M&G Plc | 5,872,847 | £35,354,539 |
Legal & General Group Plc | 5,760,126 | £34,675,958 |
HSBC Global Custody Nominee (UK) Ltd | 4,700,000 | £28,294,000 |
Ameriprise Financial, Inc. | 4,108,146 | £24,731,039 |
Columbia Threadneedle Investments (London) | 3,834,977 | £23,086,562 |
Canaccord Genuity Group Inc | 3,699,438 | £22,270,617 |
Hargreaves Lansdown Asset Management | 3,475,237 | £20,920,927 |
SERUM LIFE SCIENCES LTD | 3,382,950 | £20,365,359 |
Nine Ten Capital | 3,117,228 | £18,765,713 |
Lansdowne Partners (London) | 3,085,765 | £18,576,305 |
Mr. S Shah | 2,898,750 | £17,450,475 |
Artisan Partners | 2,620,800 | £15,777,216 |
Cubana Investments Limited | 2,506,000 | £15,086,120 |
Interactive Investor Sharedealing | 2,372,412 | £14,281,920 |
TDWaterhouse | 852,076 | £5,129,498 |
Self Trade Stockbrokers | 657,039 | £3,955,375 |
Currency | UK Pounds |
Share Price | 602.00p |
Change Today | 9.00p |
% Change | 1.52 % |
52 Week High | 613.15p |
52 Week Low | 232.50p |
Volume | 347,482 |
Shares Issued | 120.18m |
Market Cap | £723.50m |
Beta | 0.01 |
RiskGrade | 125 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 4 |
Buy | 2 |
Neutral | 4 |
Sell | 0 |
Strong Sell | 0 |
Total | 10 |
No dividends found |
Time | Volume / Share Price |
16:47 | 4,161 @ 600.54p |
16:35 | 76,565 @ 602.00p |
16:35 | 86 @ 602.00p |
16:35 | 193 @ 602.00p |
16:35 | 564 @ 602.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research